The purpose of this research study is to see if a new medication (Relamorelin) is effective for the management and treatment of Diabetic Gastroparesis. This is a Phase 3 Clinical Trial.
Thank you for your interest, but this study is not currently enrolling.
North Carolina (Orange)
Center for Gastrointestinal Biology and Disease
Clinical or Medical
Stomach, Digestion and Gut Health
Eating, Nutrition, and Metabolism